STERIS plc — Director's Dealing 2023

Jun 2, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STERIS plc (STE)
CIK: 0001757898
Period of Report: 2023-05-31

Reporting Person: Madsen Julia (Senior VP, Life Sciences)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-05-31	Ordinary Shares	F	32	$199.97	Disposed	7278	Direct
2023-05-31	Ordinary Shares	A	1734	$0.00	Acquired	9012	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-05-31	Employee Stock Options (right to buy)	$219.97	A	9740	Acquired	2033-05-31	Ordinary Shares (9740)	Direct

Footnotes

F1: 32 shares were withheld from the 92 restricted shares that vested on May 31, 2023. These 32 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 92 ordinary shares were awarded to Ms. Madsen on May 31, 2019. These vested shares were valued at the NYSE closing market price on May 31, 2023.

F2: As of May 31, 2023, 5,598 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 123 on June 1, 2023; 352 on June 2, 2023; 360 on June 2, 2023; 349 on October 2, 2023; 144 on October 2, 2023; 578 on May 31, 2024; 352 on June 3, 2024; 123 on June 3, 2024; 360 on June 3, 2024; 349 on October 1, 2024; 144 on October 1, 2024; 578 on June 2, 2025; 352 on June 2, 2025; 360 on June 2, 2025; 144 on October 1, 2025; 578 on June 1, 2026 and 352 on June 2, 2026.

F3: This option becomes exercisable as follows: 2,435 on May 31, 2024; 2,435 on June 2, 2025; 2,435 on June 1, 2026 and 2,435 on June 1, 2027.